Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis.

Ryu MS, Zhang D, Protchenko O, Shakoury-Elizeh M, Philpott CC.

J Clin Invest. 2017 May 1;127(5):1786-1797. doi: 10.1172/JCI90519. Epub 2017 Apr 4.

2.

Poly(C)-binding protein 1 mediates drug resistance in colorectal cancer.

Guo J, Zhu C, Yang K, Li J, Du N, Zong M, Zhou J, He J.

Oncotarget. 2017 Feb 21;8(8):13312-13319. doi: 10.18632/oncotarget.14516.

3.

Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Connor JR, Patton SM, Oexle K, Allen RP.

Sleep Med. 2017 Mar;31:61-70. doi: 10.1016/j.sleep.2016.07.028. Epub 2016 Nov 10.

PMID:
28057495
4.

Siderophore-mediated iron acquisition and modulation of host-bacterial interactions.

Ellermann M, Arthur JC.

Free Radic Biol Med. 2017 Apr;105:68-78. doi: 10.1016/j.freeradbiomed.2016.10.489. Epub 2016 Oct 22. Review.

PMID:
27780750
5.

A Glutaredoxin-BolA Complex Serves as an Iron-Sulfur Cluster Chaperone for the Cytosolic Cluster Assembly Machinery.

Frey AG, Palenchar DJ, Wildemann JD, Philpott CC.

J Biol Chem. 2016 Aug 12. pii: jbc.M116.744946. [Epub ahead of print]

6.

Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2.

Yanatori I, Richardson DR, Imada K, Kishi F.

J Biol Chem. 2016 Aug 12;291(33):17303-18. doi: 10.1074/jbc.M116.721936. Epub 2016 Jun 14.

PMID:
27302059
7.

Contributions to magnetic susceptibility of brain tissue.

Duyn JH, Schenck J.

NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3546. Epub 2016 May 30. Review.

8.

TLR signals posttranscriptionally regulate the cytokine trafficking mediator sortilin.

Yabe-Wada T, Matsuba S, Takeda K, Sato T, Suyama M, Ohkawa Y, Takai T, Shi H, Philpott CC, Nakamura A.

Sci Rep. 2016 May 25;6:26566. doi: 10.1038/srep26566.

9.

Poly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells.

Li F, Bullough KZ, Vashisht AA, Wohlschlegel JA, Philpott CC.

Mol Cell Biol. 2016 Jul 29;36(16):2121-31. doi: 10.1128/MCB.00104-16. Print 2016 Aug 15.

10.

Clinical iron deficiency disturbs normal human responses to hypoxia.

Frise MC, Cheng HY, Nickol AH, Curtis MK, Pollard KA, Roberts DJ, Ratcliffe PJ, Dorrington KL, Robbins PA.

J Clin Invest. 2016 Jun 1;126(6):2139-50. doi: 10.1172/JCI85715. Epub 2016 May 3.

11.

Hypoxic control of metastasis.

Rankin EB, Giaccia AJ.

Science. 2016 Apr 8;352(6282):175-80. doi: 10.1126/science.aaf4405. Epub 2016 Apr 7. Review.

12.

RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense.

Ren C, Zhang J, Yan W, Zhang Y, Chen X.

J Biol Chem. 2016 Apr 29;291(18):9629-37. doi: 10.1074/jbc.M115.712125. Epub 2016 Feb 23.

13.

Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.

Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y.

Trends Biochem Sci. 2016 Mar;41(3):274-86. doi: 10.1016/j.tibs.2015.11.012. Epub 2015 Dec 23. Review.

14.

Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

Schonberg DL, Miller TE, Wu Q, Flavahan WA, Das NK, Hale JS, Hubert CG, Mack SC, Jarrar AM, Karl RT, Rosager AM, Nixon AM, Tesar PJ, Hamerlik P, Kristensen BW, Horbinski C, Connor JR, Fox PL, Lathia JD, Rich JN.

Cancer Cell. 2015 Oct 12;28(4):441-55. doi: 10.1016/j.ccell.2015.09.002.

15.

Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS.

Emde A, Eitan C, Liou LL, Libby RT, Rivkin N, Magen I, Reichenstein I, Oppenheim H, Eilam R, Silvestroni A, Alajajian B, Ben-Dov IZ, Aebischer J, Savidor A, Levin Y, Sons R, Hammond SM, Ravits JM, Möller T, Hornstein E.

EMBO J. 2015 Nov 3;34(21):2633-51. doi: 10.15252/embj.201490493. Epub 2015 Sep 1.

16.

Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases.

Karuppagounder SS, Kumar A, Shao DS, Zille M, Bourassa MW, Caulfield JT, Alim I, Ratan RR.

Brain Res. 2015 Dec 2;1628(Pt B):273-87. doi: 10.1016/j.brainres.2015.07.030. Epub 2015 Jul 29. Review.

17.

Targeting cancer by binding iron: Dissecting cellular signaling pathways.

Lui GY, Kovacevic Z, Richardson V, Merlot AM, Kalinowski DS, Richardson DR.

Oncotarget. 2015 Aug 7;6(22):18748-79. Review.

18.

Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.

Morita T, Nakano D, Kitada K, Morimoto S, Ichihara A, Hitomi H, Kobori H, Shiojima I, Nishiyama A.

Eur J Pharmacol. 2015 Jun 5;756:85-91. doi: 10.1016/j.ejphar.2015.03.053. Epub 2015 Mar 26.

19.

Kinetics and thermodynamics of metal-binding to histone deacetylase 8.

Kim B, Pithadia AS, Fierke CA.

Protein Sci. 2015 Mar;24(3):354-65. doi: 10.1002/pro.2623. Epub 2015 Jan 13.

20.

Choosing the right metal: case studies of class I ribonucleotide reductases.

Huang M, Parker MJ, Stubbe J.

J Biol Chem. 2014 Oct 10;289(41):28104-11. doi: 10.1074/jbc.R114.596684. Epub 2014 Aug 26. Review.

Supplemental Content

Support Center